About Careers Internship MedBlog Contact us

Promising Pancreatic Cancer Treatment on the Anvil

by Rajashri on September 27, 2008 at 1:43 PM
 Promising Pancreatic Cancer Treatment on the Anvil

A new approach that may offer treatment options for pancreatic cancer has been suggested by researchers from Shanghai Jiao Tong University, China.

It is already known that overexpression of epidermal growth factor receptor or EGFR can result in cancer and targeting EGFR pathway as a potential therapeutic strategy for pancreatic cancer has been developed.


Erlotinib is a small molecule tyrosine kinase inhibitor that efficiently blocks EGFR.

The study showed significant improvement in survival with the addition of erlotinib.

The research team from Department of Gastroenterology, Affiliated First People's Hospital, Shanghai Jiao Tong University, China studied the effects of erlotinib on six different pancreatic cancer cell lines.

The researchers revealed the efficacy of erlotinib, as a single agent, on pancreatic cancer cells growth in vitro, and in vivo study using a nude mice xenograft model and the mechanisms involved were also explored.

They found that Erlotinib repressed BxPC-3 cell growth in a dose-dependent manner, triggered G1 arrest and induced cell death, and suppressed capillary formation of endothelium in vitro.

In vivo, erlotinib treated mice demonstrated a reduced tumour volume and weight as compared with control.

These findings provide evidence for the inhibitive activity of erlotinib in pancreatic cancer cells. Inhibition of EGFR may be a promising adjuvant in chemotherapeutic strategy in the treatment of the dreary disease.

The study was published in the World Journal of Gastroenterology.

Source: ANI
Font : A-A+



Recommended Readings

Latest Cancer News

Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Promising Pancreatic Cancer Treatment on the Anvil Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests